If two drugs werent in the same trial, any ranking is an indirect inference useful, but the weakest tier
The peptide's mechanism of action doesn't depend on circadian rhythms or digestive processes in the same way that other compounds might
When Wegovy/Zepbound Makes Sense Weight loss medications like Wegovy and Zepbound have a particular use case: typically, patients on the lower end of the obesity scale according to their BMI, which is 30 to 35, would be best served by losing approximately 15 to 25% of their body weight, and this may resolve many of their comorbidities
doi: 10.3389/fphar.2021.748193 Received 27 July 2021 Accepted 20 September 2021 Published 04 October 2021 Volume 12 - 2021 Edited by Jian Gao, Shanghai Childrens Medical Center, China Reviewed by Zhongling Zhang, First Affiliated Hospital of Harbin Medical University, China Chunxue Wang, Beijing Tiantan Hospital, China Updates Copyright 2021 Xue, Zhang, Xing, Liu, Zhang, Wang and Yu